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The adverse effects arising from late referral (LR) have
been reported by nephrologists over the past 20 years
from several countries [1–10]: not only does LR
delay the introduction of measures to attenuate the
progressive loss of kidney function and prevent
uraemic complications [11], but LR has also numerous
short and long-term deleterious effects on clinical
outcome [1–8]. The only study that did not conﬁrm the
long-term harmful effects of LR is the study of
Roubicek et al. [12]. It appears, however, that their
deﬁnition of LR was longer (4 months before dialysis),
patients were younger, with less co-morbidities and
relatively long hospitalization times in both patient
groups, and a shorter mean survival time of the early
referral group than in most other patient series.
While a recent review analyzed the relationships
between LR, mortality and morbidity, and the
potential positive effects of early referral [10], the
present editorial comment identiﬁes and analyzes the
different causes responsible for LR and suggests some
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actions which could reduce LR and improve the
outcome of patients with progressive kidney failure.
Some facts about late referral
According to Eadington, referral is late ‘when manage-
ment could have been improved by earlier contact
with renal services’ [13]. This has often been deﬁned
as referral of a patient with progressive kidney failure
to a nephrologist less than 3 months before the need
to start dialysis, but deﬁnitions of LR vary largely
and time limits ranging between immediate dialysis and
<6 months have been used [1–10,12–22].
LR usually leads to emergency dialysis for acute
complications such as ﬂuid overload, arterial hyper-
tension, pericarditis or gastro-intestinal complications
of uraemia; such dialysis is usually haemodialysis and
usually requires to be undertaken with a temporary
vascular access which is prone to infective and/or
other complications [23]. LR has many undesirable
consequences which have been reviewed in detail and
are summarized in Table 1.
In several European and North-American series,
and despite the different deﬁnitions, LR is frequent
and varies between 30 and 64% of the patients
initiating dialysis. This does not seem to have changed
over the last 20 years (see Table 2).
A retrospective analysis in a single unit even showed
that LR is not diminishing but may in fact increase:
it occurred in 13 out of 44 consecutive new dialysis
patients in 1985 (31%), and in 18 out of 44 consecutive
patients (41%) 10 years later – within the same unit,
the same catchment area, the same social security
system and an unchanged socio-economic back-
ground [15].
Reasons for late referral
At least 4 different reasons may explain why LR
remains a continuing problem (see Table 3).
Disease-related reasons
In some cases, LR may be unavoidable due to the
pathogenesis and mode of onset of the kidney disease,
such as irreversible acute renal failure or superimposed
acute on chronic kidney disease. De novo acute
diseases such as rapidly progressive glomerulonephritis
or systemic vasculitis may lead to referral that is
unavoidably late and at the stage of irreversible kidney
damage. On the other hand, some kidney diseases
may progress so slowly that the development of
symptoms of uraemia go almost unnoticed. Overall,
such disease-related causes do not account for more
than 15–20% of the presently observed LR cases [2,18].
Patient-related reasons
When a patient is faced with the diagnosis of
progressive kidney disease and the prospect of
(ESRD) therapy, psychological factors may play an
important role: lack of understanding of the process,
denial of the progressing disease state, fear of the
unknown, refusal to face therapeutic implications
[16,24]. The patient might even refuse the referral
proposed by the primary care physician (PCP), but this
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1981 23/55 (42%) UK Ratcliffe et al. [1]
1982–1987 274/585 (47%) USA Campbell et al. [14]
1985–1986 13/44 (31%) Switzerland Halabi et al. [15]
1989–1990 195/304 (64%) Scotland Khan et al. [16]
1989–1991 65/218 (30%) France Jungers et al. [2]
1991 24/60 (40%) Canada Levin et al. [17]
1992–1997 48/153 (32%) USA Arora et al. [5]
1994–1996 91/268 (34%) Belgium Lameire et al. [4]
1995 18/44 (41%) Switzerland Halabi et al. [15]
1997–1998 96/250 (38%) UK Roderick et al. [18]
1999–2000 502 (52%) France Kessler et al. [19]
1998–2001 137/280 (49%) Germany Schwenger et al. [20]
aDeﬁnition of late referral varied among the different studies from
<1 month to <6 months before the start of dialysis.
Table 1. Deleterious effects of late referral to the nephrologist
[1–10]
Increased mortality at short term
Increased mortality at long term
Increased morbidity
Increased costs of initial hospitalisation
Emergency dialysis and acute dialysis access
Prolonged disruption to employment
Preferential choice of center hemodialysis vs peritoneal dialysis
and transplantation
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eventuality seems to occur only in a very small
minority of cases. In contrast, co-morbid conditions,
in particular, an advanced age and/or cardio-vascular
disease, have been identiﬁed as playing an additional
role [7,16].
The distance to the centre might also be a potential
reason for LR, but in two independent studies, one
concerning an inner city population [25] and another
a rural population [26], the distance to the dialysis
centre was not a determinant factor. In contrast,
it appears that within the same Australian region,
patients living within a low socio-economic status
area were more often referred late [27].
Physician-related reasons
Causes related to the PCP and/or the nephrol-
ogist certainly explain a large proportion of the LR
pattern.
On the one hand, kidney diseases are infrequent
and complex; therefore it is difﬁcult for each PCP to
accumulate enough clinical experience for an optimal
follow-up of those patients. On the other hand, the
present debate on LR prevention is not to increase
the workload of the nephrologist, but to improve the
CKD patient care by a more integrated approach
provided by a consultation network.
Primary care physician. The PCP may directly apply to
his patients selection criteria for ESRD therapy: non-
referral is often practiced for reasons of age and/or
existing co-morbidity by the PCP [16,28,29]. This
planned conservative care may then be acutely changed
when the occurrence of advanced uraemia alarms the
patient and/or the family.
PCPs frequently fail to appreciate the beneﬁt derived
from nephrological care prior to the start of dialysis:
nephrologists are often perceived as being only
concerned with the technicalities of dialysis.
There is also a lack of appreciation of the utility of
a nephrological consultation during the early stages
of kidney failure: since no sophisticated technical
procedures are used before the initiation of dialysis,
many PCPs are of the opinion that the prescription
of phosphate binding agents or antihypertensive
drugs can be done as well by themselves as by the
nephrologist.
Of the various medical specialities with which
PCPs come in contact, nephrology is relatively rare;
nephrologists are much less numerous than cardiol-
ogists or gastro-enterologists, and therefore are less
likely to be known on a personal and regular basis.
Finally, the fear of losing clinical responsibility for
a chronic patient is an additional factor that might
play an important role, particularly in countries
with a high medical density, when care for chronic
patients on a regular basis is a source of ﬁnancial
income [30].
Nephrologist. The nephrologist is also to blame:
patient appointments may be ﬁxed late, delayed or
postponed; insufﬁcient time might be devoted to the
patient at the right moment; the contact with the
patient and his relatives may not be satisfactory; the
information or the care delivered may not be optimal;
communication concerning therapeutic strategies may
be non-existent or conveyed to the PCP in a useless
manner; and the nephrologist might even not return
the patient to the primary physician and assume with
or without the nursing staff a direct and often exclusive
role in the choice of the ESRF treatment modality [31].
Later, once the patient starts dialysis therapy, the
PCP may continue to be informed on the clinical
evolution only by the patient’s family members and
may often remain without any medical information
from the dialysis unit.
Many of those observations are favoured by the
fact that insufﬁcient numbers of nephrologists are
available, indicating again that consultation networks
instead of deﬁnitive referrals should be organised (see
below).
Dialysis centre-related. In a recent survey of a cohort
of incident dialysis patients in 4 adjacent Alpine
regions in France, Italy and Switzerland, it appeared
that LR was almost identical within the three
countries, but much more frequent in the large city
reference centers than in the regional units in each
country [32]. This observation suggests that larger
nephrological teams are usually not known on a
personal basis by the PCP and this factor might also
favour LR. Medical plethora in the large cities could
also play a role.
Furthermore, in certain countries, PCPs may be
reluctant to refer patients to a service which is
perceived as lacking in facilities and being under
resourced.
Education and communication. Campbell et al. [14]
have shown that 91% of PCPs felt they had not
received adequate training regarding time or indica-
tions for referral of patients with progressive kidney
failure.
In a survey conducted by Mendelssohn in Canada
[3], 54% of general practitioners felt that rationing
of dialysis was appropriate; 50% of the PCPs
recommended better communication and feedback
from nephrologists. Should a patient be referred to a
specialist for a diagnostic and therapeutic work-up
of microscopic haematuria? 79% of the PCP’s
responded no, for proteinuria it was 69% and for
an elevation of the serum creatinine concentration
between 1.4–1.7mg%, 83% responded no. In addi-
tion, there were 60% non-responders and it would
be surprising if the non-responders to the question-
naire would refer patients more readily than the
responders.
In a survey of Belgian dialysis units in Flanders,
Van Biesen et al. found that the following medical
specialties accounted for LR: generalists 20% of their
referred patients, internists 60%, urologists 25%,
endocrinologists 35% and cardiologists 40% [33].
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Those percentages should be taken with caution as the
majority of patients are referred by generalists and with
respect to the cardiologists, a hyper-hydrated uraemic
patient might have been referred to the cardiologist
instead of being sent directly to the nephrologist.
Nevertheless, the Diamant Alpin study also indicated
that other specialists are much more responsible for
LR than generalists [32].
In Switzerland, 850–950 new patients with terminal
kidney failure start dialysis each year. According
to the statistics of the Swiss Medical Association,
there were 9710 PCPs practicing in the country in
December 2002: internal medicine 4304, diabetology
117, cardiology 402, general medicine 3262, paediatrics
932 and 693 physicians without ofﬁcial specialist
recognition [34]. That means that one patient with
terminal kidney failure is seen by a PCP at an average
rate of one patient every 11 years. This frequency
certainly does not allow PCPs to gain enough
experience in the care of patients with progressing
kidney disease.
In a recent survey conducted by the St Vincent
Declaration of Nephropathy Working Group among
over 7000 European specialists on the optimal ﬁrst
referral of diabetic patients with evidence of kidney
disease, it appears that 84% of the nephrologists
would like to see a patient once microalbuminuria
has been established, while only 36% of the diabetol-
ogists and internists share this opinion; in contrast,
when the serum creatinine is >200 umol/l, these
percentages are 1 and 34%, respectively [35]. Again,
since only 1124 physicians responded, it would be
surprising that those who did not respond have more
homogeneous opinions.
Medical plethora could be an additional factor
responsible for the increasing LR pattern. While
the French speaking part of Belgium has one of the
highest medical densities in Europe, the LR pattern
(<3 months) remained at a high 50% between 1997
and 2000 [36]. Switzerland had 1 physician/600 inhabi-
tants in 1985, and 1/284 inhabitants in 2002; it has
been a common observation in the University hospitals
that during the 1970s patients with progressing kidney
disease were referred as soon as an abnormal serum
creatinine had been noted; during the 1980s, those
patients were referred for one single nephrological
consultation only, while during the 1990s, a phone
call asking for advice was all that was made when a
progression of kidney failure was noted.
Health care system-related reasons
Finally, the health care system per se may either favour
or impede the referral pattern.
Even in Western countries, some patients of poor
socio-economic status may have no or only limited
access to care [16,27]. Some health care plans restrict
de facto referral to specialized care or consult. In a
situation of managed care, a PCP penalizes himself
when he refers a chronic patient to a specialist.
Regulated or deregulated reimbursement of drugs
such as prescription or delivery of erythropoeitin
(EPO), biological and radiological investigations may
also play a role.
Taken globally, when Jungers et al. [2] investigated
the reasons for LR in their patients, lack of symptoms
from uraemia was responsible for 18%, physician
related reasons for 40% and patient non-compliance
for 42% of the late referrals.
Proposals to prevent late referral
Optimal referral is early referral. It allows for early
diagnostic evaluation, delays progression and prevents
the development of uraemic complications [11].
Furthermore, it allows for timely interventions to
control co-morbid conditions, for adequately prepar-
ing the patient for renal replacement therapy (includ-
ing preservation of the veins of forearm and arm) and
to start dialysis at the optimum time [37].
Recent studies have shown that the cardio-vascular
risk of CKD patients is dramatically increased not only
at the stage of dialysis, but even at very moderate
stages of kidney failure when the GFR is still at
80ml/min [38]. Insufﬁcient cardio-vascular risk man-
agement during this early phase of CKD might to, a
large extent, account for the current poor dialysis
outcomes.
Such a sophisticated therapeutic plan needs an
interwoven collaboration between PCP and nephrolo-
gists.
Improved medical education and communication
While dialysis and transplantation have been routine
therapy for almost 50 years, those domains are still
not taught adequately in most of the pre- and post-
graduate medical education programmes.
The fact that pre-dialysis care is presently not
optimal is illustrated by the two following examples.
Among 155 076 incident chronic dialysis patients
within the US health care ﬁnancing administration
between April 1995 and June 1997, the mean serum
albumin (a potent indicator of patient survival on
dialysis) was only 3.3 g/dl and 60% of the patients
had an albumin of less than 3.5 g/dl. The mean
haematocrit was 28 vol% and only 23% received
EPO during the pre-dialysis phase [39]. A survey
among 4333 newly dialyzed patients in Europe led
to similar results: 68% of the patients had an Hb
<11 g/dl at their ﬁrst visit to the dialysis unit [40].
These observations clearly illustrate that the care of
pre-dialysis patients needs improvement.
In addition, therapeutic interventions have been
demonstrated to be effective; for example, the use of
EPO during the pre-dialysis phase has an impact
on long-term mortality: among 4866 pre-dialysis
patients with a median follow-up of 26.2 months,
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EPO was given to 1107 (22.7%). After the start of
dialysis, the adjusted relative risk of death was 0.80
in the EPO treated group and only 0.67 in the sub-
group with the highest hematocrit [41].
In a 10 year study conducted at the Necker
Hospital among 1152 patients (mean age 55 years,
range 18–92), the length of the pre-dialysis care by
the nephrological team had a signiﬁcant beneﬁcial
effect on cardio-vascular morbidity and on 5 year
survival on dialysis: patients followed for <6 months
pre-dialysis had a cardio-vascular morbidity of 39.6%
and a 5 year survival of 58%, while those followed
>35 months pre-dialysis had a cardio-vascular mor-
bidity of only 21% and a 5 year survival of 77% [21].
The role of guidelines
Different nephrological Societies have published guide-
lines to improve the delivery of care and collaboration
between primary care physicians and nephrologists:
NIH Consensus Statement, Canadian Society
of Nephrology, British Renal Association, K-DOQI
guidelines, etc. [42–45]. A worldwide coordinating
group has even been recently set-up [46].
So far, however, this problem has received more
attention from the nephrological community than
from other physician groups. Our own experience
clearly indicates that the initiation of this networking is
not an easy task. Different attempts are presently
planned to improve the collaboration between PCPs
and nephrologists. To start this cooperation, an
uniﬁed and clear deﬁnition of late referral is urgently
needed.
An interwoven network
However, it has to be taken into account that PCPs are
presently faced with (too) many guidelines in many
medical ﬁelds.
It is important to stress that the referral concept
does not mean a deﬁnitive transfer of the patient to
the nephrologist; as a matter of fact there are not
enough resources or nephrologists to take care of
all those patients [47]. But since their present medical
condition at the start of dialysis is not optimal and
the vast majority of them are already identiﬁed and
followed by other medical specialists, we may expect
a substantial improvement of their medical condition by
an interwoven and precisely timed collaboration of the
concerned physicians: (1) patients at risk of developing
progressive kidney disease (i.e. patients with arterial
hypertension, diabetes mellitus, recurrent urinary tract
infections, history of familial nephropathy, etc) should
be screened by their PCP; (2) management of patients
with CKD should be shared between the PCP and the
nephrologist; the nephrologist should send the patient
back to his PCP with a detailed report and also with a
medium to long-term follow-up plan.
As a draft scheme, a time-table for work-up and
follow-up is illustrated in Table 4. This plan implies
a well-deﬁned collaborative chart on mutual fast
information and accurate data transmission.
In this context we point to the experience of
A. Levin indicating that the quality of care for
patients with progressing CKD delivered in the
Vancouver region is gradually better according to
the following order: no care, PCP, single nephrologist
and multidisciplinary renal team [17]:
Patient information should be improved. The patient
and his relatives should receive detailed and empathic
information at each stage of kidney failure. This
information should be progressive, i.e. adapted to the
patient’s level of understanding, to the different stages
of kidney failure and its progression rate.
The advantages offered by a multidisciplinary team
approach, including nursing staff, social worker,
dietician, etc and providing clinical demonstrations,
teaching material, and discussions groups have been
emphasized [17]. Contacts with other ESRF patients
and their relatives, patient’s associations, and any
written or electronic material to consult at home
should become essential tools to help such patients
cope with their deteriorating condition.
In addition, regular information campaigns directed
to the general population should make persons at
risk aware of their condition and inform them on
Table 4. Proposed time-table for a nephrological consult in an
interwoven network between primary care physicians and
nephrologists
1 When a screening or diagnostic procedure has evidenced signs
of a kidney disease
to establish or conﬁrm
diagnosis (consider kidney biopsy, interventional radiology, etc)
prognosis for general health and kidney function, genetic
counseling,
therapeutic and follow-up plan, including treatment of the
underlying disease, prevention and treatment of uraemic
complications in particular BP control (target 120/70mmHg),
osteodystrophy, proteinuria
2 Once per year, when a CKD has been diagnosed and does not
progress towards ESRD
to establish
eventual treatment of the underlying disease
prevention and treatment of uremic complications
3 When the estimated GFR declines by >20%
diagnosis of an eventual superimposed deteriorating factor
re-evaluation of the treatment of the underlying disease
re-evaluation of the prevention and treatment of uremic
complications in particular blockade of the renin-angiotensin
axis, prevention of osteodystrophy, evaluation and correction
of anemia (EPO and iron prescription), nutritional
counseling, preservation of the arm and forearm veins, . . .
information on ESRD treatment possibilities
4 When the estimated GFR is <25–30ml/min
the nephrologist should take over the general management
of the patient and establish
complete information on ESRD therapies
preparation of the dialysis access
planning of the dialysis start
CKD, chronic kidney disease; ESRD, end-stage renal failure; esti-
mated GFR, glomerular ﬁltration rate in ml/min estimated through
the Cockcroft–Gault formula [34,39–42].
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the simple clinical and biological tests to perform in
order to diagnose CKD.
Finally, health care system-related reasons could also
be improved: the referral of a patient with progressive
CKD should not penalize the patient or his PCP.
We certainly have to convince health care adminis-
trators that simple measures which allow early
detection and treatment of CKD are more cost-
efﬁcient than any expensive ESRD treatment.
Conclusions
In patients with progressing chronic kidney disease,
the trend for late referral to the nephrologist is clearly
detrimental to patients, the medical community, and
the health care system. The present review has identi-
ﬁed and systematically analyzed several factors that
favour late referral. While some disease-related causes
of late referral seem unavoidable, most other causes
could be improved effectively and rapidly, but resolu-
tion of the problem calls for improved interdisciplinary
cooperation. The setting-up of consultation networks
at the regional or local level appears as one of the most
urgent and effective steps.
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